comparemela.com

Ioana Preston News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Advancing Pulmonary Arterial Hypertension Care: Overcoming Challenges in Special Populations and Exploring Innovative Approaches

Ioana Preston, MD, highlights treatment considerations for managing PAH in specific patient populations and discusses the unmet needs that can be addressed by novel therapeutic approaches or improved treatment strategies.

Ioana prestonPulmonary arterial hypertension careOvercoming challengesSpecial populationsExploring innovative

New drug tested in Boston offers room to breathe for patients

A doctor at Tufts Medical Center worked to help develop a drug to treat pulmonary arterial hypertension, a rare but often deadly lung disease.

United statesMike bennettJessica brownIoana prestonPulmonary hypertension center at tufts medicalDrug administrationPulmonary hypertension centerTufts medical

New drug tested in Boston offers room to breathe for PAH patients

A doctor at Tufts Medical Center worked to help develop a drug to treat pulmonary arterial hypertension, a rare but often deadly lung disease.

United statesIoana prestonJessica brownMike bennettPulmonary hypertension center at tufts medicalDrug administrationPulmonary hypertension centerTufts medical

New drug tested in Boston offers room to breathe for patients

A doctor at Tufts Medical Center worked to help develop a drug to treat pulmonary arterial hypertension, a rare but often deadly lung disease.

United statesIoana prestonJessica brownMike bennettPulmonary hypertension center at tufts medicalDrug administrationPulmonary hypertension centerTufts medical

FDA approves Merck lung disease drug acquired in $11B deal

BioPharma

Louise chenAcceleron pharmaJohnson opsumitIoana prestonJoerg koglinDrug administration onCantor fitzgeraldMerck coDrug administrationTufts medicineUnited therapeutic tyvasoNew jersey based

vimarsana © 2020. All Rights Reserved.